SG Americas Securities’s Kinnate Biopharma Inc. Common Stock KNTE Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-20,819
| Closed | -$55K | – | 2950 |
|
|
2024
Q1 | $55K | Buy |
+20,819
| New | +$55K | ﹤0.01% | 2419 |
|
|
2023
Q2 | – | Sell |
-13,429
| Closed | -$84K | – | 3006 |
|
|
2023
Q1 | $84K | Buy |
13,429
+2,994
| +29% | +$18.7K | ﹤0.01% | 2706 |
|
|
2022
Q4 | $64K | Sell |
10,435
-1,479
| -12% | -$9.07K | ﹤0.01% | 2542 |
|
|
2022
Q3 | $142K | Buy |
11,914
+272
| +2% | +$3.24K | ﹤0.01% | 2311 |
|
|
2022
Q2 | $147K | Buy |
+11,642
| New | +$147K | ﹤0.01% | 2632 |
|
|
2022
Q1 | – | Sell |
-7,707
| Closed | -$137K | – | 3079 |
|
|
2021
Q4 | $137K | Sell |
7,707
-7,678
| -50% | -$136K | ﹤0.01% | 2600 |
|
|
2021
Q3 | $354K | Buy |
+15,385
| New | +$354K | ﹤0.01% | 2567 |
|
|
2021
Q1 | – | Sell |
-13,400
| Closed | -$533K | – | 3056 |
|
|
2020
Q4 | $533K | Buy |
+13,400
| New | +$533K | ﹤0.01% | 1704 |
|